TNFSF10 and melanoma: Next, to assess if Tregs primarily depend on TRAIL to suppress the antitumor response, we injected Foxp3Cre-YFP.B6 and Tnfsf10L/LFoxp3Cre-YFP.B6 mice with B16 melanoma.